Tag: FDA Safety Alert

FDA designates Class 1 recalls for aspiration catheter, infusion accessory, endotracheal tubes

Editor's Note The US Food and Drug Administration (FDA) has issued three Class I medical device recalls—the most severe category indicating risk of serious injury or death—for Q’Apel Medical Inc.’s HIPPO 072 Aspiration System and Cheetah catheter, Fresenius Kabi USA’s Blood Products Administration Set with 200 Micron Filter, and Medline…

Read More

By: Matt Danford
June 18, 2025
Share

FDA designates Class 1 recalls for intraoperative positioning guidewires, infusion pumps, dialysate

Editor's Note Centerline Biomedical’s recall of IOPS Guidewire ATW-2,  Zyno Medical’s recall of Z-800 series infusion pumps, and Nipro’s recall of MedicaLyte Liquid Bycarbonate Concentrate have been designated by the US Food and Drug Administration (FDA) as Class 1, the most serious designation indicating risk of severe injury or death.…

Read More

By: Matt Danford
June 17, 2025
Share

FDA publishes Baxter update to Novum IQ infusion pump instructions addressing underinfusion risk

Editor's Note Baxter has issued a correction notice for its Novum IQ Large Volume Pump (LVP) after identifying a serious risk of underinfusion linked to the device’s standby mode and power-off conditions. First published on April 24 on the Food and Drug Administration (FDA) website and subsequently reported by Healthcare…

Read More

By: Tarsilla Moura
June 9, 2025
Share

FDA issues early alerts for intravascular catheters

Editor's Note The US Food and Drug Administration (FDA) warned of safety risks resulting from manufacturing issues with two varieties of intravascular catheter—Conavi Medical’s Novasight Hybrid line and BD’s PowerPICC intravascular devices—in separate early alerts April 18. In one reported incident, the sheath of a Novasight Hybrid catheter—a device used…

Read More

By: Matt Danford
April 21, 2025
Share

Infusion pumps deemed high-risk in FDA early alert

Editor's Note Baxter Healthcare Corporation has issued a letter to affected customers recommending certain Spectrum infusion pumps be removed from where they are used or sold, according to a March 5 early alert from the US Food and Drug Administration (FDA). The FDA notice concerns the Sigma Spectrum Infusion System…

Read More

By: Matt Danford
March 5, 2025
Share

FDA announces multiple Class 1 recalls

Editor's Note The US Food and Drug Administration (FDA) designated Class 1 Recalls—the most severe category indicating serious risk of injury or death—for multiple devices over the past few days, including pressure monitoring systems, emergency resuscitators, fluid delivery sets, extracorporeal blood circuits, endoscope accessories, infusion pumps, and glucose/Ketone meters. These…

Read More

By: Matt Danford
February 3, 2025
Share

Infusion pump problems prompt early FDA safety warning

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

By: Matt Danford
December 12, 2024
Share

Some FDA-recalled medical devices remain in use while manufacturers implement corrections

Editor's Note A 2016 recall issued for the Abbott MitraClip cardiac device highlighted potential safety concerns, but instead of removing the product from the market, Abbott and the Food and Drug Administration (FDA) allowed continued use with revised instructions and additional training for doctors. This approach reflects a broader trend…

Read More

By: Tarsilla Moura
August 27, 2024
Share

FDA warns healthcare providers to conserve blood culture media bottles amid shortage

Editor's Note Healthcare providers should consider strategies to conserve BD BACTEC blood culture media bottles for patients at highest risk due to an ongoing shortage, according to a July 10 report from The US Food and Drug Administration (FDA). Attributing the shortage to supplier issues, FDA warns that the disruption…

Read More

By: Matt Danford
July 29, 2024
Share

FDA warns of continued cardiac pump safety concerns after series of recalls

Editor's Note The US Food and Drug Administration (FDA) is urging healthcare providers to avoid using Getinge heart devices due to continued safety concerns that remain unaddressed despite previous recalls. Issued to healthcare providers May 8, the warning letter applies to Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices…

Read More

By: Matt Danford
May 9, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat